Manteia
Xiamen
About Manteia
Manteia is committed to deep learning, data technology, and traditional algorithm research in the field of tumor radiotherapy. Manteia is headquartered in Xiamen, China, it has a wholly-owned subsidiary in the United States. It is a foreign-introduced "Double Hundred Talents" enterprise by Xiamen Municipal Government and a strategic investment enterprise in the field of radiotherapy by Fosun Group and Danlu Capital. The company has R&D teams in China and the United States, with about 50 algorithms and engineers, of which 40% are doctors and 30% are masters. The core R&D personnel have published more than 170 SCI-indexed documents in the field of radiotherapy. It has 26 software copyrights, 2 international patents and 6 domestic patents.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $31.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2024)
- Website: manteiatech.com
Industries & Categories
Data Integration, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/manteia-52823 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.